Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Baldness challenged men's self-image and masculinity in Britain from the late 19th to early 20th centuries, leading to a market for hair loss treatments.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Men are getting more beard transplants to look better and follow fashion trends.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Men and women may have different risks of getting skin cancer.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Gender affects the symptoms and severity of systemic lupus erythematosus.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Men and women need different facial rejuvenation treatments due to distinct aging processes and anatomical differences.